Colgate-Palmolive Company (NYSE:CL) boasts 85% institutional ownership, reflecting strong institutional backing. Acknowledging the company's merits, UBS included Colgate-Palmolive in the list of stocks for the AI, Growth, & Low Rates Era. With a 129-year dividend streak, it extended $0.50 quarterly payout, reinforcing its financial stability. Institutions like Sanctuary Advisors and Zacks Investment Management, acquired shares, a sign of practical investing strategies. Despite selling shares, Franklin Resources and Destination Wealth Management did not affect the company's overall positive momentum. For instance, investing in the company five years ago would have yielded a 59% gain. Colgate-Palmolive's Q3 2024 growth is impressive, coupling this with a revised 2024 outlook increases investor trust. Analyst Jim Cramer and Wall Street see potential in CL, identifying it as a top momentum stock and a possible best household care stock respectively. However, some gravitate towards undervaluation theories. Looking beyond, the company excels in maintaining steady demand, adjusting its performance forecast favorably. The intrinsic value of the company is potentially higher than its current share price, thus, making it an attractive investment for long-term growth.
Colgate-Palmolive Company CL News Analytics from Wed, 08 May 2024 07:00:00 GMT to Sat, 14 Dec 2024 11:38:12 GMT -
Rating 7
- Innovation 3
- Information 8
- Rumor 4
